Anti-Counterfeit Technology Benefit To Pharma Could Reach $1 Bil. – HDMA
Executive Summary
The financial return from adopting electronic product codes that use radio frequency identification to address Rx supply chain integrity would exceed the costs, a Healthcare Distribution Management Association report finds
You may also be interested in...
FDA Anticounterfeiting Policy: Pilot Programs Will Not Trigger Enforcement
FDA will participate in developing anticounterfeiting standards with interested parties, Senior Advisor for Medical & Health Policy Paul Rudolf, MD, said
FDA Anticounterfeiting Policy: Pilot Programs Will Not Trigger Enforcement
FDA will participate in developing anticounterfeiting standards with interested parties, Senior Advisor for Medical & Health Policy Paul Rudolf, MD, said
“Big Three” Wholesalers Will Rotate HDMA Chairmanship
The heads of the three largest members of the Healthcare Distribution Management Association will assume a rotating chairmanship of HDMA